Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Roberto Lorenzetti; Angelo Zullo; Lorenzo Ridola; Andrea Picchianti Diamanti; Bruno Laganà; Luigi Gatta; Alberto Migliore; Alessandro Armuzzi; Cesare Hassan; Vincenzo Bruzzese

doi:10.3109/07853890.2014.941919

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Roberto Lorenzetti, Angelo Zullo, Lorenzo Ridola, Andrea Picchianti Diamanti, Bruno Laganà, Luigi Gatta, Alberto Migliore, Alessandro Armuzzi, Cesare Hassan, Vincenzo Bruzzese

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

57 Citazioni (Scopus)

Abstract

Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

Lingua originale	English
pagine (da-a)	547-554
Numero di pagine	8
Rivista	Annals of Medicine
Volume	46
DOI	https://doi.org/10.3109/07853890.2014.941919
Stato di pubblicazione	Pubblicato - 2014

Keywords

Ankylosing spondylitis
anti-TNF
inflammatory bowel diseases
methotrexate
psoriasis
rheumatoid arthritis
tuberculosis

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3109/07853890.2014.941919

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Lorenzetti, R., Zullo, A., Ridola, L., Diamanti, A. P., Laganà, B., Gatta, L., Migliore, A., Armuzzi, A., Hassan, C., & Bruzzese, V. (2014). Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. Annals of Medicine, 46, 547-554. https://doi.org/10.3109/07853890.2014.941919

@article{59fc9e75ddb74085a1dcf21536cb0392,

title = "Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials",

abstract = "Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.",

keywords = "Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis, Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis",

author = "Roberto Lorenzetti and Angelo Zullo and Lorenzo Ridola and Diamanti, {Andrea Picchianti} and Bruno Lagan{\`a} and Luigi Gatta and Alberto Migliore and Alessandro Armuzzi and Cesare Hassan and Vincenzo Bruzzese",

year = "2014",

doi = "10.3109/07853890.2014.941919",

language = "English",

volume = "46",

pages = "547--554",

journal = "Annals of Medicine",

issn = "0785-3890",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

AU - Lorenzetti, Roberto

AU - Zullo, Angelo

AU - Ridola, Lorenzo

AU - Diamanti, Andrea Picchianti

AU - Laganà, Bruno

AU - Gatta, Luigi

AU - Migliore, Alberto

AU - Armuzzi, Alessandro

AU - Hassan, Cesare

AU - Bruzzese, Vincenzo

PY - 2014

Y1 - 2014

N2 - Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

AB - Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

KW - Ankylosing spondylitis

KW - anti-TNF

KW - inflammatory bowel diseases

KW - methotrexate

KW - psoriasis

KW - rheumatoid arthritis

KW - tuberculosis

KW - Ankylosing spondylitis

KW - anti-TNF

KW - inflammatory bowel diseases

KW - methotrexate

KW - psoriasis

KW - rheumatoid arthritis

KW - tuberculosis

UR - http://hdl.handle.net/10807/64556

U2 - 10.3109/07853890.2014.941919

DO - 10.3109/07853890.2014.941919

M3 - Article

SN - 0785-3890

VL - 46

SP - 547

EP - 554

JO - Annals of Medicine

JF - Annals of Medicine

ER -

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo